SCHEMBL574107

SCHEMBL574107

Cc1cc(-c2cc(C)c(NCC(O)S(=O)(=O)O)c(C)c2)cc(C)c1N

nearest known ligand 0.41

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL574612 0.92 MAPT (0.32) TDP1
SCHEMBL574676 0.83 ALDH1A1 (0.39) ALDH1A1TP53CYP3A4TSHRTDP1
SCHEMBL574611 0.76 ALDH1A1 (0.44) ALDH1A1TP53CYP3A4TSHRTDP1
SCHEMBL17601966 0.75 ALDH1A1 (0.42) ALDH1A1TP53CYP3A4TSHRTDP1
SCHEMBL5311847 0.74 CA1 (0.32) TDP1
SCHEMBL574004 0.73 ALDH1A1 (0.41) ALDH1A1TP53CYP3A4TSHRTDP1
SCHEMBL574723 0.73 ALDH1A1 (0.41) ALDH1A1TP53CYP3A4TSHRTDP1
SCHEMBL7049611 0.73 ALDH1A1 (0.41) ALDH1A1TP53CYP3A4TSHRTDP1
Sulfuric Acid SCHEMBL8521097 0.73 ALDH1A1 (0.70) ALDH1A1TP53CYP3A4TSHRTDP1
SCHEMBL753887 0.72 ALDH1A1 (0.40) ALDH1A1TP53CYP3A4TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020257930-A1 STABLE ALKYL BENZIDINE COMPOSITION AND METHODS OF MAKING AND USING SAME OneStep Technologies Inc. (CA) 2020-12-30 WO claimed
US-10597352-B1 Stable alkyl benzidine composition and methods of making and using same OneStep Technologies Inc. (CA) 2020-03-24 US claimed
WO-2020257930-A1 STABLE ALKYL BENZIDINE COMPOSITION AND METHODS OF MAKING AND USING SAME OneStep Technologies Inc. (CA) 2020-12-30 WO disclosed
US-10597352-B1 Stable alkyl benzidine composition and methods of making and using same OneStep Technologies Inc. (CA) 2020-03-24 US disclosed
US-20160084809-A1 SIMULTANEOUS DETERMINATION OF MULTIPLE ANALYTES IN INDUSTRIAL WATER SYSTEM BL TECHNOLOGIES, INC. 2016-03-24 US disclosed
US-9228986-B2 Simultaneous determination of multiple analytes in industrial water system GENERAL ELECTRIC COMPANY (US) 2016-01-05 US disclosed
EP-2601515-A1 SIMULTANEOUS DETERMINATION OF MULTIPLE ANALYTES IN INDUSTRIAL WATER SYSTEM General Electric Company (US) 2013-06-12 EP disclosed
US-20130122597-A1 SIMULTANEOUS DETERMINATION OF MULTIPLE ANALYTES IN INDUSTRIAL WATER SYSTEM BL TECHNOLOGIES, INC. 2013-05-16 US disclosed
WO-2012016350-A1 SIMULTANEOUS DETERMINATION OF MULTIPLE ANALYTES IN INDUSTRIAL WATER SYSTEM GENERAL ELECTRIC COMPANY (US) 2012-02-09 WO disclosed
US-20070224691-A1 Composition for measuring concentration of residual chlorine MIURA CO., LTD. 2007-09-27 US disclosed
EP-1837653-A1 Composition for measuring concentration of residual chlorine MIURA CO., LTD. (JP) 2007-09-26 EP disclosed
EP-1770394-A2 Composition for measuring residual chlorine concentration MIURA CO., LTD. (JP) 2007-04-04 EP disclosed
US-20070072305-A1 Composition for measuring residual chlorine concentration MIURA CO., LTD. 2007-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10597352-B1 Stable alkyl benzidine composition and methods of making and using same C9, BBC3, CTRC ALDH1A1 828/4885TP53 607/4885CYP3A4 830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.